Breakthrough Breast Cancer and Breast Cancer Campaign have appointed Baroness Delyth Morgan as Chief Executive of the new charity that will be formed by their merger.

Wednesday 18 March 2015      General
Baroness Delyth Morgan appointed Chief Executive of UK’s leading breast cancer charity

Baroness Delyth Morgan

Breakthrough Breast Cancer and Breast Cancer Campaign have appointed Baroness Delyth Morgan as Chief Executive of the new charity that will be formed by their merger.

The new charity – officially formed on 1 April 2015 – will have at its heart a firm commitment to end breast cancer once and for all using the combined expertise, knowledge, capacity and research portfolios of the two charities.

Chief Executive of Breast Cancer Campaign since July 2011, Delyth was appointed by Chair Lynne Berry OBE and representatives of the charity’s Board of Trustees on Friday 13 March, following an open recruitment process.

Delyth enjoyed a varied career in the voluntary sector before her appointment to the House of Lords in 2004. Ten years as Chief Executive at Breakthrough Breast Cancer followed roles at Asthma UK, Shelter and Workplace Nurseries Campaign.

She was appointed to Government in 2007, serving as Children’s Minister, Intellectual Property Minister and Quality and Government spokesperson for the Department of Work and Pensions in the House of Lords, before returning to breast cancer at the helm of Campaign in 2011.

As Baroness Morgan of Drefelin, Delyth now sits in the House of Lords as an independent peer. She is a Founding Fellow of Breakthrough Breast Cancer, Fellow of University College London, Honorary Fellow of the Institute of Cancer Research and Cardiff University. She is Patron of Pancreatic Cancer UK and The Sheila McKechnie Foundation, and Honorary President of Cancer 52.

Having jointly managed the preparations for merger of the two charities with Chris Askew, Chief Executive at Breakthrough Breast Cancer, Delyth will play an integral role in defining, establishing and leading the organisation towards its strategic ambitions.

Baroness Delyth Morgan, newly appointed Chief Executive of the new charity, said:

“When I started at Breakthrough Breast Cancer in 1996 there were 15,000 women a year dying of breast cancer; now there are 12,000. It goes without saying that this is still too many.

“This job to me is both professional and personal. It is a great honour and leadership challenge to have been selected to lead these two great charities, merging into one to finally end breast cancer.

“Leading this new charity is the opportunity to finish the job. Collaboration and enterprise will be essential - we must harness the incredible progress in science to deliver more targeted treatment, using a strong single voice to aid consistently high quality care, early detection and prevention wherever possible.

“Crucially, we cannot do it alone. We need anyone and everyone who is involved in and affected by breast cancer to stand with us.”

Lynne Berry OBE, chair of the new charity, said: “We are absolutely delighted to welcome Delyth as chief executive of our new charity. Delyth is a transformational leader, whose warmth and unshakeable passion to make a difference for all those affected by breast cancer made her the outstanding candidate for the role, in an extremely strong field.

“I’d like also to thank Chris Askew for his remarkable contribution as CEO of Breakthrough and in his joint chief executive role with Delyth to deliver such a bold merger.”

Isla Smith, Chair of Trustees for Breast Cancer Campaign, said:

“Delyth’s wealth of experience in the voluntary sector, the political arena and in the field of breast cancer, ideally equips her not just to lead, but also to inspire the work of the new charity. She is devoted to the fight against breast cancer and we look forward to seeing the bold work of the new charity under her leadership.”

Stephanie Monk, Chair of Trustees for Breakthrough Breast Cancer, said:

“A year ago we set out on the path to create a new breast cancer charity and it is incredibly exciting to be so close to seeing it come to life. Together we will become a single, strong advocate for those affected by breast cancer; emboldened to fundraise like never before, and leading with a cohesive scientific programme, designed to help us achieve our aims faster.

“Our shared ambition will become our joint aim; to stop women dying from breast cancer.”

Breakthrough and Campaign will formally merge on 1 April and will relocate to a new head office location in Aldgate, London ahead of the launch of the new charity in late Spring 2015.